Archives: Products

The UFT300 Helicobacter pylori quick test is a rapid urease test that has transformed the diagnostic process and reporting of H. pylori infection in endoscopy settings. Unlike other urease tests, the UFT300 H. pylori quick test takes just 5 minutes, delivering reliable results that can be entered directly into your endoscopy reporting system and discussed with patients before they’ve even left the endoscopy theatre.

The UFT300 Helicobacter pylori quick test is a rapid urease test that has transformed the diagnostic process and reporting of H. pylori infection in endoscopy settings. Unlike other urease tests, the UFT300 H. pylori quick test takes just 5 minutes, delivering reliable results that can be entered directly into your endoscopy reporting system and discussed with patients before they’ve even left the endoscopy theatre.

Preventis® SmarTest® FIT Home test is a quantitative home test system for measuring hidden (occult) traces of blood in stool samples. This in vitro diagnostic device (IVD) is intended for self-testing to support screening for colorectal cancer and adenomatous polyps in patients who may benefit from further investigations.

Determination of free therapeutic certolizumab

Certolizumab is the Fab’ fragment of a recombinant humanised antibody conjugated to polyethylene glycol (PEG) and is therefore also known as “certolizumab pegol”. The IDKmonitor Certolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free certolizumab therapeutic drug in serum and EDTA plasma samples.

Preventis SmarTest Calprotectin Home test is a quantitative home test system for measuring calprotectin in stool samples. This in vitro diagnostic device (IVD) is intended for self-testing and individual monitoring of disease activity and treatment efficacy for patients with chronic inflammatory bowel disease (IBD).

The GA-Map Dysbiosis test is the first clinical test that identifies and characterises dysbiosis based on faecal specimens. It does this by exploiting single nucleotide differences in the 16S rRNA gene – a gene that is common to all bacteria. With 48 highly specific probes, the GA-map Dysbiosis Test identifies over 300 species of bacteria using cutting edge high throughput technology.

This MAb is specific to human tissue extracellular matrix components such as vitronectin, with no cross-reaction with other matrix molecules. It can be used in immunohistochemical staining, immunoblotting and other immunoassays for cellular and tumour biology research. Purified vitronectin from human plasma is used as an immunogen for antibody production.

This human cytoskeletal polypeptide MAb can be used in immunoblotting, immunohistochemical staining and other immunoassays for cellular and tumour biology research. In immunoblotting, it identifies a 130 kD polypeptide. Vinculin, purified from human smooth muscle tissue, is used as an immunogen for antibody production.

This human cytoskeletal polypeptide MAb recognises vimentin with an Mr of 57,000 in mesenchymal cells, and can be used in immunohistochemical staining and western blotting. Purified vimentin, obtained via electrophoresis from cultured human fibroblasts, is used as an immunogen for antibody production.

This human extracellular MAb interacts with the fourth and fifth fibronectin-like repeats of human tenascin-C polypeptides with an Mr of 250,000 and 180,000. It can cross-react with humans, guinea pigs and rabbits. It can also be used in immunohistochemical staining, western blotting and other immunoassays for cellular and tumour biology research, as well as for quantitation of Tenascin-C in body fluids. Purified tenascin-C from human fetal fibroblasts is used as an immunogen for antibody production.

This MAb identifies the Mr-250,000 and Mr-180,000 human tenascin polypeptides in immunoprecipitation, or just the Mr-250,000 polypeptide in immunoblots. It can also interact with the fibrinogen-like knob domain of the tenascin protein, especially in paraffin sections of human tissue. It can be used in immunofluorescence, immunoblotting and immunohistochemistry on formalin-fixed or paraffin-embedded sections. Tenascin polypeptides isolated from the spent culture supernatant of human fibroblasts by affinity chromatography are used as immunogens for antibody production.

This MAb interacts with both cellular and plasma forms of fibronectin, and has an affinity for cellular binding regions. It can cross-react with humans and guinea pigs. This antibody can be used in immunohistochemical staining, western blotting, and other immunoassay methods for cellular and tumour biology. Purified fibronectin from A8387 fibrosarcoma cells is used as an immunogen for antibody production.

This human gastric biomarker MAb is specific to human pepsinogen II, with no cross-reactivity to human pepsinogen I. It is suitable for immunohistochemical staining, western blotting and enzyme immunoassays. Pepsinogen II – purified from human tissue – is used as an immunogen for antibody production.

This human gastric biomarker MAb is specific to human pepsinogen I, with no cross-reactivity to human pepsinogen II. It is suitable for immunohistochemical staining, western blotting and enzyme immunoassays. Pepsinogen I – purified from human tissue – is used as an immunogen for antibody production.

This MAb to human endothelial cell surface markers interacts with Mr-135,000 PECAM-1 polypeptides from leukocytes and endothelial cells. It can also detect all breast endothelial cells, and identifies erythroid differentiation in human leukemic cells. It can be used in immunohistochemical staining, western blotting and other immunoassays for cellular and tumour biology. Ulex Europaeus-agglutinin-I reactive glycoproteins – taken from cultured human umbilical vein endothelial cells – were isolated by lecithin-affinity chromatography and used as immunogens for antibody production.

This human cytoskeletal polypeptide MAb interacts with Mr-68,000 and Mr-200,000 neurofilament proteins in human tissues. It can be used in immunohistochemical staining and western blotting. Purified neurofilament triplet proteins from the human spinal cord are used as immunogens for antibody production.

This cytoskeletal polypeptide MAb interacts with all three neurofilament protein molecules – Mr 68,000, Mr-150,000 and Mr-200,000 – in mice, as well as Mr-150,000 and Mr-200,000 in human tissues. It can be used in immunohistochemical staining and western blotting. Purified neurofilament triplet proteins from human spinal cords were used as immunogens to produce this MAb.

This MAb interacts with the Mr-200,000 γ1-chain of human-reduced and alkylated laminin; a protein synthesised by cultured cells. The specificity of this antibody was confirmed by immunoprecipitation and ELISA, using a recombinant γ1-chain. It only reacts with human cells and tissues and, although it does not work in western blotting, it can be used in immunohistochemical staining and immunoprecipitation. Pepsin-digested laminins from human placenta are used as immunogens for antibody production.

This MAb interacts with the NH2-terminus of the β1-chain subunit of laminin with a molecular mass (Mr) of 220,000. It can be used in human tissues for immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology. This clone reacts strongly both under reducing and non reducing conditions. It can also be successfully used to purify laminin-8 and laminin-10 using affinity chromatography, unlike many other antibodies to the laminin β1-chain. Partially pepsin-digested laminins from human placenta are used as immunogens for antibody production.

This MAb recognises and interacts with human genistein. There is some cross-reactivity with daidzein (3.3 %), dihydrodaidzein (2.5 %), dihydrogenistein (0.4 %), and glycitein (0.3 %), but none with equol or O-DMA. It can be used for enzyme or fluorescent immunoassays, and is produced using BSA-conjugated human genistein as an immunogen.

This MAb is specific to the human gastric biomarker protein hormone gastrin-17, though it has no cross-reactivity to gastrin-34 or cholecystokinin. It can be used in immunohistochemical staining and enzyme immunoassays. Synthetic gastrin-17 coupled to thyroglobulin is used as an immunogen for antibody production.

This MAb is highly specific to the human neurotransmitter, GABA, with a weak interaction against the β-alanine BSA-conjugate antigen, but only at the highest concentrations. There is no interaction with any other amino acid-BSA conjugates. It can be used in fluorescence microscopy and other immunohistochemical methods, as well as on frozen sections, provided they have been perfusion fixed beforehand. Glutaraldehyde must be included in the fixative of paraffin sections, if they are used. GABA coupled to BSA with glutaraldehyde is used as an immunogen for antibody production.

This MAb is specific to the 220 kD human erythroid -spectrin protein, present in skeletal muscle cell membranes. It can be used to identify erythroid leukaemia, to monitor the integrity of muscle cell plasma membranes, and in various immunochemical reactions, immunoprecipitation, western blotting, as well as immunocytochemistry methodologies. Ghost proteins from human red blood cells are used as immunogens for production of this antibody.

This MAb is specific to the 240 kD human erythroid α-spectrin protein. It can be used to detect erythroid spectrin or to identify erythroid leukaemia, and also in various immunochemical reactions, immunoprecipitation, western blotting, as well as immunocytochemistry methodologies. Ghost proteins from human red blood cells are used as immunogens for production of this antibody.

This MAb interacts with the cytokeratin 8, 18 and 19 genes, found in many simple epithelial cells, and it can be used in Immunohistochemical staining and western blotting. Purified cytokeratin – from cultured pig kidney epithelial cells – is used as an immunogen for production of this antibody.

This MAb interacts with the cytokeratin 7, 17 and 19 genes, found in many simple and squamous epithelial cells, and it can be used in immunohistochemical staining and western blotting. Purified cytokeratin – from cultured pig kidney epithelial cells – is used as an immunogen for production of this antibody.

This MAb identifies the cytokeratin 18 gene (CK18), coding for a type I intermediate filament protein found mainly in simple epithelial cells. It interacts with a variety of different species, especially mouse CK18, and can be applied in developmental biological and gene knockout studies, as well as for immunohistochemical staining, western blotting and immunoprecipitation. Cytokeratin – isolated from cultured pig kidney epithelial cells – is used as an immunogen for production of this antibody.

This MAb is highly specific to CGRPs, remaining inactive with other neuropeptides. It functions within human and guinea pig tissue, but not rat. It can be used in ELISA, fluorescence microscopy, immunoblotting with BSA-conjugated samples, and other immunohistochemical methods, as well as on frozen sections providing they have undergone perfusion fixation. Paraformaldehyde must be included in the fixative with paraffin sections, if used. A terminal fragment of the CGRP, coupled to BSA with glutaraldehyde, is used as an immunogen for antibody production.

This MAb is specific to the extradomain A sequence of human fibronectin. It cross-reacts with humans, rats, chickens, rabbits and guinea pigs, and can be used in immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology. Purified fibronectin from A8387 fibrosarcoma cells is used as an immunogen for antibody production.

This MAb interacts with the β3 human integrin, including the GPIIIa complex on platelets. It can be used for immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology research. A partially purified platelet glycoprotein IIb/IIIa complex is used as an immunogen for production of this antibody.

This MAb interacts with the extracellular β1 subunit epitope of the human integrin protein family. It can be used for immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology research, as well as immunofluorescence staining of paraffin sections. Wheat germ agglutinin-binding glycoproteins from human fibroblasts are used as immunogens for antibody production.

This MAb to human integrins interacts with the extracellular β1 subunit epitope of the integrin protein family. It can be used for immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology research, as well as immunofluorescence staining of paraffin sections. Wheat germ agglutinin-binding glycoproteins from human fibroblasts are used as immunogens for antibody production.

This is a MAb specific to the 240 kD human cytoskeletal polypeptide α-fodrin of all non-erythroid mammalian cells, as well as α-spectrin in chickens. It cross-reacts with humans, rats, chickens, rabbits and guinea pigs, and can be used for immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology research. Red blood cell membranes from chickens are purified by hypotonic lysis and mechanical enucleation, and used as immunogens for antibody production.

This is a MAb specific to the 100 kD human cytoskeletal polypeptide α-actinin, interacting with human and chicken cells. It can be used for immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology research. Purified alpha-actinin from chicken gizzard is used as an immunogen for production of antibodies.

The MAb to human integrins can be used for immunohistochemical staining, immunoblotting and other immunoassays for cellular or tumour biology research. It interacts with the IIb-subunit of β-integrins, specifically on platelets, megakaryocytes and leukemic cells that undergo megakaryocytic differentiation. A partially purified platelet glycoprotein IIb/IIIa complex is used as an immunogen for antibody production.

The IDK anti-SARS-CoV-2 quantitative IgG ELISA is for the specific detection and quantification of human IgG antibodies against the SARS-CoV-2 spike protein.

The GP Reader is used in combination with the GastroPanel Quick Test NT and enables the rapid and precise measurements of the test results.

Stool samples can be extracted directly and efficiently using the IDK Stool Sample Application System, which allows easy, clean and precise preparation of sample extracts.

Stool samples can be extracted directly and efficiently using the IDK Stool Sample Application System, which allows easy, clean and precise preparation of stool sample extracts.

Stool samples can be extracted directly and efficiently using the IDK TurbiTUBE, which allows easy, clean and precise preparation of sample extracts.

Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. This assay enables the reliable determination of free, unbound anti-drug antibodies.

Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. This drug-tolerant assay enables the reliable determination of anti-drug antibodies even in the presence of ustekinumab.

BIOHIT Faecal Calprotectin Extraction Tubes are intended for the extraction of human stool samples for measurement of calprotectin using the BIOHIT Calprotectin ELISA.

The BIOHIT GastroPanel Quick Test is a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori (H. pylori) and atrophic gastritis in a clinic or point-of-care setting.

Sample collection tubes for saliva samples

The IDK TurbiPEL is a particle enhanced turbidimetric immunoassay (PETIA) that uses monoclonal antibodies for the determination of human pancreatic elastase in stool samples.

The IDK TurbiFIT employs a particle-enhanced turbidimetric immunoassay (PETIA) methodology, utilising polyclonal antibodies to accurately quantify human haemoglobin levels in stool samples.

The IDK TurbiCAL is a particle enhanced turbidimetric immunoassay (PETIA) that uses monoclonal antibodies for the determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples.

BIOHIT supplies various accessories for its ELISA automate systems, offering flexible customisation to suit a range of assays.

BIOHIT’s DSX is a fully automated, four-plate processing system that can perform multiple assays per plate. The DSX’s modular design provides flexible configuration and was developed with ease of use in mind. The system incorporates many features that ensure the quality and security of results, and it can handle a wide variety of assays, offering reliable sample-in/result-out processing for true walkaway automation.

BIOHIT’s DS2 automated ELISA processor offers full walkaway capability, allowing users to quickly and easily process two 96-well microplates and up to 12 different assays simultaneously. It features a user-friendly control system, chain of custody management and on-board instrument diagnostics for straightforward, reliable operation and traceability.

The BIOHIT Analyser is a compact, cost-efficient system for automation of BIOHIT’s GastroPanel® assay and other ELISAs. This processor’s completely open architecture allows programming of any ELISA protocol, for walkaway automation of up to 192 patient samples. An optional CLIA module extends the analyser’s capabilities to include chemiluminescence assays.

The BP 800 Microplate Reader has all the features of a modern microplate photometer, with optional pre-programmed protocols for BIOHIT assays. New test protocols can be created quickly and easily with the help of an intuitive user interface. Extensive on-board data reduction surpasses many PC software packages, including curve-fitting, cut-off calculation, data transformation and validation capabilities. The instrument can also be controlled with a computer for further processing and distribution of data.

The BP 808 Microplate Reader has all the features of a modern microplate photometer, with optional pre-programmed protocols for BIOHIT assays. This powerful microplate reader, with integrated keypad and LCD display, has extensive on-board data reduction with curve-fitting, cut-off calculation, data transformation and validation capabilities.

The BIOHIT Quick Test Reader (QTR), for the BIOHIT lateral flow ColonView and Celiac quick tests, provides clear negative or positive confirmation of the test line visual reading by stating ‘not visible’ or ‘visible’, respectively. ​The QTR can connect to PCs for data management and administration in a medical network such as LIS (HL7) protocols, and you can export data from the reader data bank using the Data Viewer software.

The PepCube is a portable, handheld and easy-to-use lateral flow device that enables the fast quantification of pepsin in saliva samples using Peptest. Each read takes just three seconds and can be used to evaluate the results either qualitatively or quantitatively. Results are displayed on the screen and reported in ng/ml.​

The BW50 Microplate Washer allows full and precise fluidic control, from gentle drip-based delivery to fully pressurised washing. This self-contained and programmable instrument is the perfect companion for BIOHIT’s BP-series readers. The intuitive on-board software can be programmed in the same way as both the BP 800 and 808, so that washing and data reduction protocols can be easily developed.

PreventID CalDetect 50/200 is a rapid immunochemical test that semi-quantitatively screens and measures calprotectin in stool samples in just 10 minutes. Faecal calprotectin is an exceptionally accurate and convenient marker for investigating bowel inflammation in patients presenting with abdominal symptoms, or monitoring those with inflammatory bowel disease (IBD).

Preventis SmarTest Pro Vitamin D is a rapid test system for the quantitative determination of 25(OH) vitamin D in finger-prick blood samples, ideal for GPs, pharmacies and outpatient clinics. This quantitative test supports fast and effective vitamin D supplement optimisation, and enables close monitoring of 25(OH) vitamin D levels in a point of care setting. The kit contains everything needed to prepare, collect and test a finger-prick blood sample in combination with the SmarTest Vitamin D app.

The CE-marked GA-map COVID-19 Fecal Test is designed to qualitatively detect SARS-CoV-2 RNA in faecal samples. This kit is suitable for patients exhibiting symptoms of COVID-19 (confirmation and management), as well as those in the recovery phase (surveillance and clearance), asymptomatic individuals concerned about possessing and transmitting the virus (prevention), and for screening faecal microbiota transplant (FMT) donors.

BIOHIT’s series of unified kits feature methods that have been standardised across all analytes and optimised for automation. This assay is part of the BIOHIT GastroPanel product.

Most people experience stomach discomfort, upsets, or abdominal pain at some point throughout their lives and in the majority of cases these are caused by transient issues or functional dyspepsia.

The BIOHIT Gastrin-17 kit is a microplate-based quantitative ELISA for the determination of human amidated gastrin-17 from plasma or serum samples. This test identifies Helicobacter pylori (H. pylori)-infected patients who have advanced atrophic gastritis in the gastric antrum.

BIOHIT ColonView Hb and Hb/Hp test can be used to screen for lower gastrointestinal (GI) organic pathologies, such as colorectal cancers and large adenomas that bleed. ColonView is a new generation lateral flow faecal immunochemical test (FIT), intended for the rapid detection of faecal occult blood (FOB) in stool samples.

The BIOHIT H. pylori Quick Test is a rapid, one-step urease test to detect H. pylori infection from a biopsy sample during gastroscopy. It can also be used to evaluate the success of eradication therapy. This easy-to-use, gel-based test employs a simple colour indicator that allows easy visual confirmation of positive results in as little as two minutes – and negative results after 30 minutes – without specialist training.

The BIOHIT UFT300 Helicobacter pylori Quick Test is an ultra-fast urease test that has revolutionised the way H. pylori infection is diagnosed and reported in gastroscopy. With extremely high accuracy and every result available within five minutes, this ready-to-use test is the choice for endoscopists.

The BIOHIT Total 25OH Vitamin D ELISA is a quantitative immunoenzymatic assay for the determination of 25-hydroxyvitamins D2 and D3 (25OHD2 and 25OHD3) in serum and plasma, to aid in the diagnosis of vitamin D deficiency, insufficiency or intoxication.

The BIOHIT Calprotectin ELISA is a quantitative sandwich ELISA method for the detection of calprotectin in stool samples. It can be used to help identify organic diseases of the small or large intestine, and to monitor disease activity and response to treatment in patients with ulcerative colitis or Crohn’s disease.

The BIOHIT Active B12 (holotranscobalamin) ELISA directly measures holotranscobalamin (holoTC) – the biochemically active form of vitamin B12 – from human serum. This test is well-suited for the screening of patients with a suspected vitamin B12 deficiency, and overcomes the problems associated with traditional testing methods that measure total, rather than just active, vitamin B12 concentration.

The BIOHIT Celiac Quick Test is a rapid immunochromatographic test for the qualitative detection of antibodies (IgA, IgG, IgM) against human tissue transglutaminase (tTG2A) in capillary whole blood samples.

Peptest is an innovative, non-invasive diagnostic test to help identify reflux, and is especially critical in detecting silent reflux. Based on quantitative lateral flow technology, Peptest detects the presence of pepsin in clinical samples from the upper digestive and respiratory tracts.

The BIOHIT Lactose Intolerance Quick Test supports the diagnosis of lactose intolerance (hypolactasia of the small intestine) by detecting lactase enzyme activity in a duodenal biopsy specimen.

The BIOHIT Pepsinogen II kit is a microplate-based quantitative ELISA for the determination of human pepsinogen II from plasma or serum samples. This test is intended as an additional tool in the diagnosis of atrophic corpus gastritis, which is also a risk state for gastric cancer.

The BIOHIT Pepsinogen I kit is a microplate-based quantitative ELISA for the determination of human pepsinogen I from plasma or serum samples. This test is intended to identify patients who have advanced atrophic gastritis in the gastric corpus, and are therefore at increased risk of developing gastric cancer.

The IDK Zonulin (Stool) ELISA is a quantitative assay designed for the precise determination of zonulin levels in stool samples. Zonulin, a protein intricately involved in intestinal barrier function, has garnered attention as a potential marker for the phenomenon commonly known as “leaky gut” syndrome.

The IDK Zonulin (Serum) ELISA is a quantitative assay for the determination of zonulin in serum. Zonulin is a protein that is involved in intestinal barrier function, and has been highlighted as a potential marker of so called “leaky gut” syndrome.

The IDK Pancreatic Elastase ELISA is a quantitative enzyme immunoassay for the determination of pancreatic elastase in stool samples. This supports the diagnosis of exocrine pancreatic insufficiency in a range of cases including unexplained diarrhoea, gut microbiota, dysbiosis, IBS/IBD, steatorrhoea, flatulence, weight loss, upper abdominal pain and dietary intolerances.

The IDK H. pylori Stool Antigen ELISA is used for the detection of H. pylori in stool samples, for confirmation of active H. pylori infection in the absence of atrophic gastritis, bleeding ulcer and use of proton pump inhibitors.

The IDK Lactoferrin ELISA is an enzyme immunoassay for the quantitative determination of lactoferrin – a well-established biomarker for neutrophilic intestinal inflammation – in stool samples. Faecal lactoferrin measurement supports monitoring of disease activity in inflammatory bowel disease (IBD), prediction of relapse of IBD and assessment of treatment response in IBD.

The IDK Faecal Calprotectin ELISA is an enzyme immunoassay for the quantitative determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples, to rule out and monitor inflammatory bowel diseases (IBDs) non-invasively.

The innovative IDK Faecal Bile Acids assay allows quantitative determination of bile acids in stool samples. This rapid photometric assay can aid the diagnosis of bile acid diarrhoea in patients with diarrhoea-predominant irritable bowel syndrome (D-IBS) or can be used to support differential diagnosis of bile acid malabsorption.

The IDK Faecal Haemoglobin ELISA stands as a cutting-edge enzyme immunoassay designed to deliver precise quantitative measurements of human haemoglobin in stool samples. This assay serves as a crucial marker for identifying early colorectal cancer and adenomatous polyps by detecting gastrointestinal bleeding, particularly originating from colorectal adenomas and tumours.

The IDKmonitor Vedolizumab Free Anti-drug ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free anti-vedolizumab antibodies in plasma or serum samples. Detecting high levels of free anti-vedolizumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.

The IDKmonitor Rituximab Drug Level ELISA kit is a microplate-based quantitative assay for the determination of free rituximab from plasma or serum samples. Rituximab is a chimeric therapeutic monoclonal antibody (mAb) that targets B-cells (CD-20) in the treatment of rheumatoid arthritis, non-Hodgkin’s B-cell lymphomas, lymphocytic leukaemia, active granulomatosis with polyangiitis and microscopic polyangiitis.

Vedolizumab is a recombinant protein used to treat Crohn’s disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples.

Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples.

Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.

Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Golimumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free golimumab in plasma or serum samples.

IDKmonitor Etanercept Free Anti-drug Antibody ELISA is a quantitative assay that detects human antibodies against etanercept in EDTA plasma and serum samples. Etanercept is a human therapeutic monoclonal antibody used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis.

The innovative IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis.

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free therapeutic TNFα antibodies (adalimumab) from plasma or serum samples.

Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation which is a major cause of loss of drug response.

Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

The IDK Oncostatin M (OSM) ELISA is used for the quantitative determination of oncostatin M in serum, plasma or stools. OSM and its receptor, OSMR, are involved in gut inflammation, and are upregulated in the mucosa of IBD patients.